The latent phase of necrotic liver degeneration in the rat, produced by dietary deficiency of vitamin E and Factor 3, is characterized by respiratory decline, i.e., a failure of respiration of liver slices in the Warburg. Tocopherol readily reverses this defect when injected intravenously but not when added to the Warburg medium. The in vitro effect of various tocopherol derivatives on respiratory decline was investigated. DL-α-tocopherol, d- α-tocopheryl polyethylene glycol-1000 succinate, DL-α-tocopherylhydroquinone, DL-α-tocopherylquinone, and DL-“α-tocopheroxide” (acetal of α-tocopherylquinone) did not influence the breakdown of respiration. Two tocopherol metabolites, isolated from the urines of rabbits and humans, 2-(3-hydroxy-3-methyl-5-carboxy)-pentyl-3,5,6-trimethylbenzoquinone and its γ-lactone, were found to prevent respiratory decline when added to the Warburg medium. A dose response curve was obtained. The 50% effective dose was at approx. 6.25 μg. The diacetate of the hydroquinone of the lactone was active at higher dose levels. The significance of the findings is discussed. In addition to the effect on respiratory decline, the γ-lactone at levels of 100 μg per flask produced a stimulation of the initial O 2 consumption. The stimulatory effect was less pronounced, but present, with liver slices from normal controls.
Read full abstract